Ablative Solutions, Inc. announced it raised $54.5 Million in an amended filing from an offering of $91.5 Million

Company

Location

About

Ablative Solutions is a clinical-stage medical device start-up that is pioneering the novel approach of Transcatheter Perivascular Alcohol Denervation for the treatment of hypertension. Hypertension, or high blood pressure, is a modern day epidemic, affecting more than one billion people worldwide and an estimated 67 million in the United States alone. Often described as "the silent killer"​, hypertension is strongly associated with heart disease and stroke.